Renaissance Technologies - ADAGIO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ADAGIO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$83
+232.0%
48,785
+101.6%
0.00%
Q2 2023$250.0%24,200
+18.0%
0.00%
Q1 2023$25
+4.2%
20,500
+29.7%
0.00%
Q4 2022$2415,8000.00%
Other shareholders
ADAGIO THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 9,248,250$9,710,66312.83%
Alphabet Inc. 5,680,785$5,964,8240.32%
683 Capital Management, LLC 4,000,000$4,200,0000.30%
Bain Capital Life Sciences Investors, LLC 1,937,207$2,034,0670.21%
TANG CAPITAL MANAGEMENT LLC 1,151,843$1,209,4350.18%
Slate Path Capital LP 3,735,000$3,921,7500.14%
BML Capital Management, LLC 134,696$141,4310.13%
Orbimed Advisors 5,270,400$5,533,9200.10%
Redmile Group, LLC 1,440,725$1,512,7610.06%
MAVERICK CAPITAL LTD 2,338,373$2,455,2920.05%
View complete list of ADAGIO THERAPEUTICS INC shareholders